Skip to content
Epiontis ID Logo
  • Technology
  • Applications
  • Resources
  • Contact
  • Home
  • Technology
  • Applications
  • Resources
  • Contact
Filters

Effects on CD3, Treg, and TH17 Cell Numbers in Skin Biopsies After 16-Week Mirikizumab Treatment, Evaluated by an Epigenetic Assay

Carlos Bonilla2022-08-08T17:01:14-04:00Resources|

Read More

Interim Biomarker Analysis of Etigilimab (OMP-313M32), an Anti-TIGIT Antibody, in Advanced Solid Tumors Supports TIGIT-Associated Mechanisms of Action

Carlos Bonilla2022-08-08T17:01:39-04:00Resources|

Read More

Epigenetic Immunophenotyping in Monitoring of SARS-CoV-2 Vaccine Response and COVID-19 Disease Course

Carlos Bonilla2022-08-08T17:11:46-04:00Resources|

Read More

Selective Induction of Activated Regulatory T-Cells in Healthy Volunteers by NKTR-358, a Novel IL-2 Conjugate Treg Stimulator, in Development for the Treatment of Autoimmune Diseases

Carlos Bonilla2022-08-08T17:05:53-04:00Resources|

Read More

Etrolizumab Treatment Increases Blood Levels of CD3, Treg and Th17 Cells Measured Through Epigenetic Activation of CD3, FOXP3 and IL-17 Loci

Carlos Bonilla2022-08-08T17:06:12-04:00Resources|

Read More

Evidence of Target Engagement and Modulation: Biomarker Analysis of the Phase 1b Inhaled Seralutinib Study

Carlos Bonilla2022-08-08T17:08:56-04:00Resources|

Read More
  • Home
  • Technology
  • Applications
  • Resources
  • Contact
© Precision Medicine Group, LLC.
All Rights Reserved.
Privacy Policy GDPR



By continuing to use our website, you agree to our use of cookies to help us give you the best experience, analyze your site usage, and assist in our marketing efforts.
For more information, or to learn how to change your cookies preferences, please click here.

OK